MPS-LOC ReadyCell
ReadyCell Communications Department
21 February 2024
ProgrammeProyectos de I+D+i en Líneas Estratégicas 2022 (MICIN)
Budget79.541 Euros
Duration2022-2025 (36 months)
ConsortiumLeitat (project coordinator), Vall d’Hebron Institut de Recerca, ReadyCell

The primary goal of this project, MPS-LOC “Microphysiological systems based on liver-on-chip for drug discovery and testing”, is to develop liver-on-chip systems that integrate microfluidics, 3D printing, human-derived liver cells, and liver-derived bioinks. These systems aim to replace animal models in drug discovery, offering higher predictive value in preclinical drug development.

These liver-on-chip devices are expected to represent human liver physiology and function more accurately for drug discovery, and their adaptability to include multi-donor pooling could provide data that better reflects the diverse metabolisms found in the population.

Related posts

Happy International Women’s Day!

Happy International Women’s Day!

With this infographic, we proudly show the key facts we have achieved in recent times in promoting gender equality and women’s rights in the company.